Rare diseases
Investigational molecules
Locations
Back to France69 clinical trials in Cholet, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceStudy on Adding Ipilimumab to Atezolizumab and Bevacizumab for Patients with Liver Cancer Receiving First-Line Treatment
FranceStudy on Atezolizumab, Bevacizumab, and Paclitaxel for Advanced Lung Cancer Patients After Immunotherapy and Chemotherapy
FranceFranceStudy on the Effectiveness of Co-Trimoxazole for Treating Ventilator-Associated Pneumonia in ICU Patients Compared to a Drug Combination
FranceStudy on Alpelisib and Fulvestrant or Ribociclib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer with PIK3CA Mutations
FranceComparison of drug combinations containing irinotecan, oxaliplatin, fluorouracil and folinic acid for treatment of high-risk stage III colon cancer
FranceStudy of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy
FranceStudy on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on lung cancer treatments, including innovative combinations of immunotherapy and chemotherapy. Multiple trials exploring new approaches for breast cancer management, particularly in triple-negative and hormone-positive cases.
Several studies investigating novel drug combinations and personalized treatment approaches for various cancer types.
Comprehensive research into heart failure prevention and treatment, including studies on novel drug combinations. Investigations of stroke prevention in patients with atrial fibrillation and management of cardiovascular risks.
Focus on developing innovative therapeutic approaches for various cardiac conditions.
Advanced research in severe asthma treatment and respiratory care, including studies of new therapeutic agents. Investigation of oxygen therapy protocols in intensive care settings.
Emphasis on improving treatment outcomes for patients with severe respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
